This inventor holds 3 USPTO granted patents. Top assignee: Japan Energy Corporation. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2001
Title: Tominaga Fukazawa: Innovator in Pharmaceutical Chemistry
Introduction
Tominaga Fukazawa is a notable inventor based in Toda, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel dipeptide compounds. With a total of 3 patents to his name, Fukazawa's work focuses on compounds that exhibit promising therapeutic effects.
Latest Patents
Fukazawa's latest patents include innovative methods for preparing dipeptide compounds and their pharmaceutically acceptable salts. One of his key inventions provides a synthetic methodology to produce these compounds, which demonstrate excellent HIV protease inhibitory activity and bioavailability from digestive tracts. Another patent outlines a novel dipeptide compound that serves as an effective ingredient in anti-AIDS agents, showcasing the potential of his research in combating serious health issues.
Career Highlights
Fukazawa is associated with Japan Energy Corporation, where he applies his expertise in pharmaceutical development. His work has garnered attention for its potential impact on HIV treatment and related therapies. His innovative approaches to synthesizing dipeptide compounds highlight his commitment to advancing medical science.
Collaborations
Fukazawa has collaborated with notable colleagues, including Ryohei Kato and Tsutomu Mimoto. These partnerships have likely contributed to the success and breadth of his research endeavors.
Conclusion
Tominaga Fukazawa stands out as a significant figure in the field of pharmaceutical chemistry, with his innovative patents paving the way for advancements in HIV treatment. His contributions reflect a dedication to improving health outcomes through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile